We provide you with 20 years of free, institutional-grade data for RCUS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RCUS. Explore the full financial landscape of RCUS stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$18,758
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Azoy Alexander | Sale | -1,579 | $11.88 | $18,758 | 2025-09-05 |
| KANEKO YASUNORI | Grant, award...etc | 13,300 | 2025-06-12 | ||
| Lacey David L. | Grant, award...etc | 13,300 | 2025-06-12 | ||
| Lambert Nicole | Grant, award...etc | 13,300 | 2025-06-12 | ||
| Machado Patrick | Grant, award...etc | 13,300 | 2025-06-12 | ||
| PERLMAN ANDREW J | Grant, award...etc | 13,300 | 2025-06-12 | ||
| Ribas Antoni | Grant, award...etc | 13,300 | 2025-06-12 | ||
| FALBERG KATHRYN E | Grant, award...etc | 13,300 | 2025-06-12 | ||
| ROSEN TERRY J | Open Market Purchase | 19,800 | $10.18 | 2025-02-27 | |
| KANEKO YASUNORI | Open Market Purchase | 20,000 | $10.06 | 2025-02-27 | |
| GILEAD SCIENCES, INC. | Open Market Purchase | 1,363,636 | $11 | 2025-02-20 | |
| Markus Richard | Grant, award...etc | 75,193 | 2025-02-11 | ||
| Goeltz II Robert C. | Grant, award...etc | 37,000 | 2025-01-27 | ||
| Azoy Alexander | Grant, award...etc | 17,100 | 2025-01-27 | ||
| Jaen Juan C. | Grant, award...etc | 50,000 | 2025-01-27 | ||
| Tang Carolyn C. | Grant, award...etc | 37,000 | 2025-01-27 | ||
| Jarrett Jennifer | Grant, award...etc | 50,000 | 2025-01-27 | ||
| ROSEN TERRY J | Grant, award...etc | 165,000 | 2025-01-27 | ||
| Goeltz II Robert C. | Sale | -3,594 | $15 | $53,910 | 2025-01-03 |
| Nuyten Dimitry SA | Sale | -7,856 | $16.08 | $126,324 | 2024-12-17 |
| Goeltz II Robert C. | Sale | -10,099 | $16.08 | $162,392 | 2024-12-17 |
| Azoy Alexander | Sale | -2,969 | $16.08 | $47,742 | 2024-12-17 |
| Jaen Juan C. | Sale | -17,286 | $16.08 | $277,959 | 2024-12-17 |
| Jarrett Jennifer | Sale | -27,501 | $16.08 | $442,216 | 2024-12-17 |
| Tang Carolyn C. | Sale | -11,339 | $16.08 | $182,331 | 2024-12-17 |
| ROSEN TERRY J | Sale | -37,882 | $16.08 | $609,143 | 2024-12-17 |
| Azoy Alexander | Sale | -201 | $15.32 | $3,079 | 2024-12-04 |
| Jarrett Jennifer | Sale | -12,670 | $17.95 | $227,427 | 2024-09-17 |
| Nuyten Dimitry SA | Sale | -5,385 | $17.95 | $96,661 | 2024-09-17 |
| Azoy Alexander | Sale | -1,357 | $14.97 | $20,314 | 2024-08-15 |
| Jarrett Jennifer | Sale | -12,670 | $16.97 | $215,010 | 2024-06-18 |
| ROSEN TERRY J | Sale | -12,670 | $16.97 | $215,010 | 2024-06-18 |
| Jaen Juan C. | Sale | -6,969 | $16.97 | $118,264 | 2024-06-18 |
| Tang Carolyn C. | Sale | -4,182 | $16.97 | $70,969 | 2024-06-18 |
| PERLMAN ANDREW J | Grant, award...etc | 8,400 | 2024-06-07 | ||
| Lambert Nicole | Grant, award...etc | 8,400 | 2024-06-07 | ||
| Ribas Antoni | Grant, award...etc | 8,400 | 2024-06-07 | ||
| Machado Patrick | Grant, award...etc | 8,400 | 2024-06-07 | ||
| Lacey David L. | Grant, award...etc | 8,400 | 2024-06-07 | ||
| KANEKO YASUNORI | Grant, award...etc | 8,400 | 2024-06-07 | ||
| FALBERG KATHRYN E | Grant, award...etc | 8,400 | 2024-06-07 | ||
| Jarrett Jennifer | Sale | -11,551 | $17.55 | $202,720 | 2024-03-29 |
| Jarrett Jennifer | Sale | -13,449 | $17.84 | $239,930 | 2024-03-20 |
| Jarrett Jennifer | Sale | -58,625 | $20.07 | $1,176,604 | 2024-02-28 |
| Jaen Juan C. | Sale | -27,032 | $20.06 | $542,262 | 2024-02-28 |
| Goeltz II Robert C. | Grant, award...etc | 22,000 | 2024-02-23 | ||
| GILEAD SCIENCES, INC. | Open Market Purchase | 15,238,095 | $21 | 2024-01-31 | |
| ROSEN TERRY J | Grant, award...etc | 100,000 | 2024-01-25 | ||
| Jarrett Jennifer | Grant, award...etc | 40,000 | 2024-01-25 | ||
| Nuyten Dimitry SA | Grant, award...etc | 28,000 | 2024-01-25 | ||
| Goeltz II Robert C. | Grant, award...etc | 21,300 | 2024-01-25 | ||
| Tang Carolyn C. | Grant, award...etc | 26,700 | 2024-01-25 | ||
| Jaen Juan C. | Grant, award...etc | 40,000 | 2024-01-25 | ||
| Azoy Alexander | Grant, award...etc | 8,850 | 2024-01-25 | ||
| Goeltz II Robert C. | Sale | -2,004 | $20 | $40,080 | 2024-01-04 |
| Jaen Juan C. | Sale | -6,975 | $20.09 | $140,128 | 2024-01-04 |
| Jarrett Jennifer | Sale | -21,521 | $17.76 | $382,213 | 2023-12-26 |
| Azoy Alexander | Sale | -282 | $14.95 | $4,216 | 2023-12-05 |
| Jarrett Jennifer | Sale | -21,369 | $19.99 | $427,166 | 2023-09-26 |
| Jarrett Jennifer | Sale | -45,000 | $20.25 | $911,250 | 2023-07-31 |
| Azoy Alexander | Sale | -1,018 | $20.41 | $20,777 | 2023-07-05 |
| GILEAD SCIENCES, INC. | Open Market Purchase | 1,010,000 | $19.26 | 2023-06-30 | |
| Jarrett Jennifer | Sale | -12,437 | $19.12 | $237,795 | 2023-06-26 |
| Ribas Antoni | Grant, award...etc | 6,800 | 2023-06-16 | ||
| Lacey David L. | Grant, award...etc | 6,800 | 2023-06-16 | ||
| Machado Patrick | Grant, award...etc | 6,800 | 2023-06-16 | ||
| KANEKO YASUNORI | Grant, award...etc | 6,800 | 2023-06-16 | ||
| FALBERG KATHRYN E | Grant, award...etc | 6,800 | 2023-06-16 | ||
| Lambert Nicole | Grant, award...etc | 6,800 | 2023-06-16 | ||
| PERLMAN ANDREW J | Grant, award...etc | 6,800 | 2023-06-16 | ||
| Jarrett Jennifer | Sale | -12,563 | $19.35 | $243,094 | 2023-06-16 |
| Goeltz II Robert C. | Sale | -4,049 | $20.04 | $81,142 | 2023-06-09 |
| Jarrett Jennifer | Sale | -8,729 | $16.81 | $146,734 | 2023-03-20 |
| Azoy Alexander | Initial | 2023-03-10 | |||
| Jarrett Jennifer | Sale | -1,900 | $23.56 | $44,764 | 2023-01-30 |
| Jaen Juan C. | Grant, award...etc | 45,800 | 2023-01-25 | ||
| ROSEN TERRY J | Grant, award...etc | 105,700 | 2023-01-25 | ||
| Goeltz II Robert C. | Grant, award...etc | 34,000 | 2023-01-25 | ||
| Nuyten Dimitry SA | Grant, award...etc | 34,000 | 2023-01-25 | ||
| Tang Carolyn C. | Grant, award...etc | 34,000 | 2023-01-25 | ||
| Jarrett Jennifer | Grant, award...etc | 45,800 | 2023-01-25 |
The information provided in this report about RCUS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Arcus Biosciences, Inc(NYSE:RCUS) 
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 a...
Website: http://www.arcusbio.com
Founded: 2015
Full Time Employees: 139
Sector: Healthcare
Industry: Biotechnology